VRML News and Press, Aspira Womens Health From 06/11/20

AUSTIN, Texas, June 11, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on ovarian cancer risk assessment, today announced a major rebranding to reflect the company’s continuing evolution towards becoming a compreh...

Vermillion (NASDAQ: VRML ) subsidiary ASPIRA Labs has finished validating Roche's Elecsys Anti-SARS-CoV-2 antibody blood test in addition to several new oncology biomarkers. More news on: Vermillion, Inc., Healthcare stocks news, Stocks on the move, Read more ...

AUSTIN, Texas, June 10, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is excited to announce that its wholly-owned subsidiary ASPIRA Labs has completed laboratory validation of the Roche Elecsys ...

AUSTIN, Texas, June 09, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it is set to join the broad-market Russell 3000 ®  Index at the conclusion of the 2020 Russell...

Vermillion, Inc. (VRML) Q1 2020 Earnings Conference Call May 14, 2020 04:30 PM ET Company Participants Valerie Palmieri – President and Chief Executive Officer Chris Goulart – Senior Vice President of Commercial Operations Bob Beechey – Chief Financial Office...

AUSTIN, Texas, May 14, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the first quarter March 31, 2020. “Despite late first quarter challenges f...

AUSTIN, Texas, April 30, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will report financial results for the first quarter ended March 31, 2020, on Thursday, May 14, 202...

AUSTIN, Texas, April 14, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ: VRML) today announced its wholly owned subsidiary, ASPiRA LABS, is now credentialed with Florida’s State Medicaid program for an estimated additional 3.6 million credentialed Medicaid lives. Florida has th...

AUSTIN, Texas, March 27, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ: VRML), a bioinformatics-based women’s health company focused on gynecologic disease, announced yesterday that its wholly owned subsidiary, ASPiRA Labs, has signed a national preferred agreement with Cigna. Th...

VRML (VRML) Q4 2019 Results Conference Call March 26, 2020 04:30 PM ET Company Participants Valerie Palmieri - President and CEO Bob Beechey - CFO Chris Goulart - SVP, Commercial Operations Conference Call Participants Jeb Terry - Aberdeen Investment Management Jack Frase...